Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease
Antioxidants · 20.06.2024 · 13 (6) · 751
DOI: 10.3390/antiox13060751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 20.06.2024. Verfasst von On Ying Angela Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Departmental Start-up Fund for M.H.Y.Y. from The Hong Kong Polytechnic University., Departmental Start-up Fund.
Abstract (Originalsprache)
Chronic kidney disease (CKD) presents a substantial global public health challenge, with high morbidity and mortality. CKD patients often experience dyslipidaemia and poor glycaemic control, further exacerbating inflammation and oxidative stress in the kidney. If left untreated, these metabolic symptoms can progress to end-stage renal disease, necessitating long-term dialysis or kidney transplantation. Alleviating inflammation responses has become the standard approach in CKD management. Medications such as statins, metformin, and GLP-1 agonists, initially developed for treating metabolic dysregulation, demonstrate promising renal therapeutic benefits. The rising popularity of herbal remedies and supplements, perceived as natural antioxidants, has spurred investigations into their potential efficacy. Notably, lactoferrin, Boerhaavia diffusa, Amauroderma rugosum, and Ganoderma lucidum are known for their anti-inflammatory and antioxidant properties and may support kidney function preservation. However, the mechanisms underlying the effectiveness of Western medications and herbal remedies in alleviating inflammation and oxidative stress occurring in renal dysfunction are not completely known. This review aims to provide a comprehensive overview of CKD treatment strategies and renal function preservation and critically discusses the existing literature’s limitations whilst offering insight into the potential antioxidant effects of these interventions. This could provide a useful guide for future clinical trials and facilitate the development of effective treatment strategies for kidney functions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
- The School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Alex Ngai Nick Wong, George Pak-Heng Leung, Martin Ho Yin Yeung
Förderung
- This study was supported by Departmental Start-up Fund for M.H.Y.Y. from The Hong Kong Polytechnic University.
- Departmental Start-up Fund
Zitieren
APA
Lee, O. Y. A., Wong, A. N. N., Ho, C. Y., Tse, K. W., Chan, A. Z., Leung, G. P., Kwan, Y. W., & Yeung, M. H. Y. (2024). Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease. Antioxidants, 13(6), 751. https://doi.org/10.3390/antiox13060751
Vancouver
Lee OYA, Wong ANN, Ho CY, Tse KW, Chan AZ, Leung GP, et al. Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease. Antioxidants. 2024;13(6):751. doi:10.3390/antiox13060751
BibTeX
@article{Lee2024,
author = {Lee, On Ying Angela and Wong, Alex Ngai Nick and Ho, Ching Yan and Tse, Ka Wai and Chan, Angela Zaneta and Leung, George Pak-Heng and Kwan, Yiu Wa and Yeung, Martin Ho Yin},
title = {Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {6},
pages = {751},
doi = {10.3390/antiox13060751}
}
EUVIMED